Skip to main content
HOLISTA COLLTECH LIMITED logo

HOLISTA COLLTECH LIMITED — Investor Relations & Filings

Ticker · HCT ISIN · AU000000HCT4 ASX Manufacturing
Open in API
Filings indexed 813 across all filing types
Latest filing 2017-04-03 Governance Information
Country AU Australia
Listing ASX HCT

About HOLISTA COLLTECH LIMITED

https://www.holistaco.com

Holista CollTech Limited is a research-driven company focused on the development and commercialization of natural health products and ingredients. The company specializes in three primary areas: ovine collagen, food-grade ingredients, and infection control solutions. Its proprietary collagen extraction technology produces high-quality, disease-free ovine collagen for the cosmetic and medical industries. In the food sector, the company develops low-glycemic index (GI) formulations for staple foods like bread, noodles, and pasta to address global health concerns such as diabetes and obesity. Additionally, Holista CollTech offers natural sanitization products based on plant-derived active ingredients. The company aims to provide scientifically validated solutions that enhance wellness and food quality through sustainable and natural processes.

Recent filings

Filing Released Lang Actions
Appendix 4G 14 pages 251.2KB
Governance Information Classification · 95% confidence The document is titled 'Appendix 4G' and is described as a 'Key to Disclosures Corporate Governance Council Principles and Recommendations' for the financial year ended 31 December 2016. It references ASX Listing Rules 4.7.3 and 4.10.3, which require entities to lodge a completed Appendix 4G at the same time as their annual report. The document contains detailed disclosures about corporate governance practices, compliance with ASX Corporate Governance Council recommendations, and explanations for any deviations. It is a governance-related disclosure document, not a full annual report or financial statement. The content focuses on governance principles, board structure, and compliance with governance recommendations, which aligns with the definition of Governance Information (CGR). The document length (15,000 characters) and detailed governance content confirm it is not a brief announcement or a certification letter, so it is not RPA or RNS. Therefore, the appropriate classification is Governance Information (CGR).
2017-04-03 English
HCT to Supply Medical Grade Collagen to Keneric Medical 3 pages 451.4KB
Regulatory Filings Classification · 95% confidence The document is an ASX announcement detailing a commercial agreement between Holista CollTech Ltd and Keneric Medical for the supply of medical-grade collagen. It discusses the business deal, market potential, product details, and company information. There are no financial statements, regulatory certifications, voting results, or management changes. The content is a corporate announcement about a business development and partnership, not a financial report, earnings release, or regulatory filing. Therefore, it fits best under the category of a general regulatory announcement or compliance document that does not fit other specific categories, which is Regulatory Filings (RNS). The document length (7841 characters) and detailed content confirm it is not a brief report publication announcement or a short notice.
2017-04-02 English
Annual Report to shareholders 86 pages 3.9MB
Regulatory Filings
2017-04-02 English
Appendix 3B / Change of Director's Interest Notice 10 pages 889.7KB
Capital/Financing Update Classification · 100% confidence The document is titled 'APPENDIX 3B New issue announcement' and references specific ASX rules (2.7, 3.10.3, 3.10.4, 3.10.5) related to securities issuance and quotation. It contains detailed information about the class, number, terms, issue price, purpose of securities issued, and compliance with ASX listing rules. It also includes a quotation agreement and calculation of placement capacity under ASX rules 7.1 and 7.1A. The document is a formal announcement of new securities issuance and application for quotation on the ASX, consistent with Appendix 3B filings used in Australian markets for capital raising disclosures. It is not a full financial report, earnings release, or management discussion, but a regulatory announcement about capital raising and securities issuance. Therefore, the appropriate classification is 'Capital/Financing Update' (CAP). The document length (15,000 characters) and content confirm it is a substantive announcement, not a brief notice or report publication announcement.
2017-03-26 English
Appendix 3B 8 pages 472.8KB
Capital/Financing Update Classification · 100% confidence The document is titled 'APPENDIX 3B New issue announcement' and references specific ASX rules (2.7, 3.10.3, 3.10.4, 3.10.5) related to securities issuance and quotation. It details the issuance of new securities, including options and shares, their terms, issue prices, and the calculation of placement capacity under ASX rules 7.1 and 7.1A. The document is a formal announcement to the ASX regarding new securities issued by the company, including details necessary for compliance and quotation on the exchange. It does not contain financial statements, earnings data, management discussion, or other report content. It is a regulatory announcement specifically about capital raising and securities issuance. Therefore, it fits the category of Capital/Financing Update (CAP). The document length (15,000 characters) and detailed content support this classification with high confidence.
2017-03-22 English
Preliminary Final Report 15 pages 417.7KB
Interim / Quarterly Report Classification · 95% confidence The document is titled 'Appendix 4E Preliminary Final Report 31 December 2016' and contains detailed financial statements including consolidated statement of profit or loss, comprehensive income, and financial position for the six months ended 31 December 2016. It includes operational review, principal activities, financial results, and future plans. The document is about 15,000 characters long, indicating it is a full report rather than a brief announcement. Appendix 4E is a regulatory form used in Australia for preliminary final reports, which are interim reports covering a period shorter than a full fiscal year, often transitional periods. The content includes actual financial data and analysis for a 6-month period, consistent with an Interim / Quarterly Report. It is not a full annual report (10-K), nor a simple announcement or certification. Therefore, the appropriate classification is Interim / Quarterly Report (IR). H2 2016
2017-02-28 English

Browse filings by year

23 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.